Showing results (171-180 of 294) with videos related to

Sort By:
Pageof 30
Current Cancer Drug Targets|August 3, 2013
Evaluating treatment response of chronic myeloid leukemia: emerging science and technologyAntonia Cagnetta, Anna Garuti, Carlo Marani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion proteinClaudia Balducci, Marten Beeg, Matteo Stravalaci, et al.
Current Biology : CB|November 19, 2013
The GTPase-activating protein RN-tre controls focal adhesion turnover and cell migrationAndrea Palamidessi, Emanuela Frittoli, Nadia Ducano, et al.
Infection|March 30, 2017
Good tolerability of high dose colistin-based therapy in patients with haematological malignanciesSara Grignolo, Paola Tatarelli, Fabio Guolo, et al.
Journal of Applied Microbiology|July 30, 2024
Genomic analysis of enterococci carrying optrA, poxtA, and vanA resistance genes from wild boars, ItalyMarzia Cinthi, Sonia Nina Coccitto, Francesca Romana Massacci, et al.
The Journal of Biological Chemistry|January 31, 2013
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivoBrian R Fluharty, Emiliano Biasini, Matteo Stravalaci, et al.
Annals of Medicine|May 5, 2023
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activityFrancesca Re, Sofia Giorgetti, Barbara Biondi, et al.
Pageof 30